Categories
Essays
Links
Category Archives: Conference
James Carroll received the T.H. Maiman Award for outstanding research during the Academy for Laser Dentistry award ceremony
James Carroll, CEO of THOR Photomedicine, a speaker at the 2019 CSSP Spring Leadership Workshop, received the T.H. Maiman Award for outstanding research during the Academy for Laser Dentistry’s (ALD) award ceremony at their annual conference (April 8-10), during which Red Light Therapy’s role in revolutionizing medical care was showcased. Kathleen Maiman, widow of Laser inventor Theodore Maiman, presented the award.
Carroll, a Fellow of the Royal Society of Medicine, is considered the world’s leading proponent of using Red Light Therapy, also known as Photobiomodulation (PBM). He has written or co-authored twenty-four academic papers and co-authored four books on the subject.
Carroll is working with 36 medical institutions, including Harvard Medical School, St. Jude Children’s Hospital, Veterans’ Hospitals, and the UK National Health Service (NHS), on using PBM for treating a range of conditions such as traumatic brain injury, the side effects of cancer treatments, managing acute and chronic pain, and reducing opioid use.
“My lifelong goal is having PBM accepted as a first-line medical treatment. I look forward to continuing this quest with all of you as we make PBM a global standard of care.” stated Carroll upon accepting the award.
PBM devices are cleared by the Food & Drug Administration. PBM’s success as a breakthrough medical technology is documented in 700 Clinical Trials and over 100 million patient treatments.
News source: Council of Scientific Society Presidents
Maiman (inventor of the laser) Award goes to THOR CEO
Posted in Conference, Industry, James in Action, Special Feature
on James Carroll received the T.H. Maiman Award for outstanding research during the Academy for Laser Dentistry award ceremony
Managing Oral Mucositis with PBM
Annette Quinn, RN, MSN | UPMC Hillman Cancer Centers, Pittsburgh, Pennsylvania
This session focuses on the use of Photobiomodulation (PBM) in the management of oral mucositis in oncology patients.
Educational Objectives
- Identify the prevalence of oral mucositis (OM) in the oncology population.
- Describe the benefits of PBM in the management of OM in this population.
- Identify barriers to implementing a PBM program in oncology
Read more: https://www.thorlaser.com/oralmucositis/
View current photobiomodulation therapy training dates in your location.
Disclaimer: These comments by healthcare professionals and their patients are solely their own. They are uncompensated personal stories about how they have used, or been impacted by, light therapy. These uses have not been reviewed or cleared by FDA.
Posted in Conference, Industry, Information Videos, Research, Video of the Week
on Managing Oral Mucositis with PBM
The story of how LLLT / Photobiomodulation was discovered
This is an extraordinary lecture. It is the story of how LLLT / Photobiomodulation was discovered, and because of the context in which it occurred you might also find it very moving, so get some tissues. It is an hour and 10 minutes long so get comfortable, maybe get some popcorn and a drink too. I will paste the email that Andrew Mester wrote into the comments section below.
Here is the email from Andrew Mester :
I had the privilege to give a keynote presentation at the most recent NAALT (North American Association of PhotobiomoduLation Therapy) meeting in February 5, 2017 in Coronado Island, San Diego. The title of paper was: “Invention of Laser Biostimulation”. My lecture is in Youtube now.
BACKGROUND:
Photo-medicine is an exciting new field in both scientific and clinical research all over the world and most recently in the USA. I learned in this interesting meeting that low intensity laser and LED light may stimulate, heal and regenerate neural tissue. Possible treatments are under investigation regarding traumatic events (stroke, traumatic brain injury and global ischemia), degenerative diseases (dementia, Alzheimer and Parkinson’s disease) and psychiatric disorders (PTSD, depression and anxiety). Most American studies are sponsored by the NIH (Michael Hamblin, PhD, Mass General Hospital) and by the VA (Margaret Naeser, PhD at Boston Jamaica Plain VA Hospital).
My association to this field is that my Father, Endre Mester, MD published first biostimulatory effect of the low power laser in 1967. My father, myself and my brother, Adam Mester, MD have published all the basic both research and clinical studies in the literature. We described the stimulatory effect primarily in wound healing and also the systemic effect of laser irradiation which is used now in all of the above mentioned research protocols.
My father is called in the literature the “Father of Photobiomodulation”.
The NAALT society established an Award named after my father: “Professor Endre Mester Award who made the seminal observation on the therapeutic benefits of low dose laser treatments”. The award recognizes a clinician or researcher who has made significant contributions to our understanding of light-biological tissue interactions and its therapeutic benefits, specifically in the area of Photobiomodulation Therapy. I was asked to present this award to Michael Hamblin, PhD from Massachusetts General Hospital, Harvard Medical School because of his lifetime achievements in Photobiomodulation.
Andrew Mester MD
Posted in Conference, Information Videos, Interviews, Special Feature, Video of the Week
on The story of how LLLT / Photobiomodulation was discovered
Annette Quinn – Oral Mucositis Academy of Laser Dentistry 2016
Annette Quinn, RN, MSN speaking at Academy of Laser Dentistry about how Photobiomodulation Therapy reduces oral mucositis.
PHOTOBIOMODULATION / LLLT IS HELPFUL FOR:
- Oral mucositis
- Hyposalivation and xerostomia
- Lymphoedema
OTHER EMERGING APPLICATIONS
- Radiation dermatitis
- BRONJ
- Dysphagia
- Trismus
- Fibrosis
- Pain control
Read more: https://www.thorlaser.com/oralmucositis/
View current photobiomodulation therapy training dates in your location.
Posted in Conference, Industry, Information Videos, Research, Video of the Week
on Annette Quinn – Oral Mucositis Academy of Laser Dentistry 2016
Two Special Conferences
A joint meeting of the North American Association for Laser Therapy (NAALT) and the World Association for Laser Therapy (WALT) in Washington DC, USA in 9-12 September 2014. click here. Call for abstracts is still open.
The Optical Society of America hosts “LLLT – the path forward” : LLLT/PBM, is will soon be 50 years old. Hundreds of positive clinical trials and thousands of laboratory studies have been published yet it has not been adopted by mainstream medicine. This meeting will address the reasons for this failure and identify paths forward. Washington DC 20-22 August 2014. This is a small invited guests only meeting, if you would like an invitation then submit your credentials here for consideration.
Posted in Conference
on Two Special Conferences
SPIE Abstract deadline 12 July 2010
Next January 2011 in San Francisco we will have the sixth annual conference on “Mechanisms for low light therapy VI” . The meeting this year in San Francisco was highly successful and next year’s will continue the tradition I am therefore pleased to be able to invite you to submit an abstract (Deadline 12 July 2010) and a conference proceedings paper (Deadline 15 Dec 2010) to “Mechanisms for low light therapy VI” Conference BO108 Part of SPIE’s International Symposium on Biomedical Optics (BiOS) 22 – 27 January 2011 at the Moscone Convention Center, San Francisco, California, USA. BO108 is expected to be held on Sat Jan 22.
Submit your abstract here http://spie.org/bo108
submit your abstract here
http://spie.org/bo108
Michael R Hamblin Ph.D.
Associate Professor
Department of Dermatology
Harvard Medical School
BAR 414
Wellman Center for Photomedicine
Posted in Conference
on SPIE Abstract deadline 12 July 2010
Sydney LLLT conference program 27 Sept 2009
Posted in Conference
on Sydney LLLT conference program 27 Sept 2009
Featured Testimonials